FDA approves first generic Copaxone
Processing speed deficit reduces memory technique effectiveness
Treadmill exercise found to offer cognitive benefits
Vv SkiVvys offers discount to MS patients, supports MSF
Imaging procedure may clarify disease progression
Teleconference Tonight: Be Your Own Advocate
New molecule may lead to inflammation inhibitor
Superheroes and ambassadors assemble
Unless otherwise specified, all medical content is compiled by MSF staff and reviewed for accuracy by a member of our Medical Advisory Board.
The MSF strives to present clear and unbiased information. This site is partially funded through a grant from Bayer Healthcare, LLC.
Website Design by SimplexWeb
© Copyright 2000-2013 Multiple Sclerosis Foundation - All Rights Reserved